Orthocell LtdASX: OCC

Striate US Market Entry Update

· Issued by Orthocell Ltd

Filed with ASX · · 2 pages · English

• US Key opinion leader sales growth milestone of 1,500 Striate+™ units achieved • Approvals received to upgrade existing facility and scale up Striate+™ manufacturing capacity to >100,000 units per year • Commissioning of upgraded facility expected Q4 CY2022 • Distributor discussions progressed and the Company is in advanced discussions to engage its first US distributor andestablish Striate+™ as

Orthocell Ltd on 6ix

Earlier from Orthocell

Later from Orthocell

All Orthocell news releases